TLR7 agonist 19

Compound 14 (TLR7 agonist 19) is a potent small molecule activator of Toll-like receptor 7, demonstrating favorable pharmacokinetics. It shows synergistic antitumor efficacy in research models, supporting its investigation in immuno-oncology for both in vitro and in vivo studies.